Rite Aid receives noncompliance notification from Nasdaq

Rite Aid announced that the NYSE informed the company that it is no longer in compliance with NYSE continued listing standards set forth in Section 802.01B and Section 802.01C of the NYSE’s Listed Company Manual. Under the NYSE rules, the company is provided with certain cure periods and the company’s common stock will continue to be listed and traded on the NYSE during the cure periods, subject to the company’s compliance with other continued listing requirements. The current noncompliance with the NYSE listing standards does not affect the company’s ongoing business operations or its U.S. Securities and Exchange Commission reporting requirements, nor does it trigger any violation of its material debt or other obligations.